Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurol
    May 2024
  1. FOXE D, Irish M, Carrick J, Cheung SC, et al
    Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task.
    J Neurol. 2024 May 7. doi: 10.1007/s00415-024-12406.
    >> Share

  2. CANU E, Rugarli G, Coraglia F, Basaia S, et al
    Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort.
    J Neurol. 2024;271:2716-2729.
    >> Share

    April 2024
  3. WANG S, Zheng X, Huang J, Liu J, et al
    Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies.
    J Neurol. 2024 Apr 24. doi: 10.1007/s00415-024-12380.
    >> Share

  4. GUILOFF AE, Rudge P
    Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials.
    J Neurol. 2024 Apr 13. doi: 10.1007/s00415-024-12361.
    >> Share

  5. LAVROVA A, Pham NTT, Vernon CJ, Carlos AF, et al
    A multimodal clinical diagnostic approach using MRI and (18)F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathy.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12312.
    >> Share

  6. MENDES AJ, Ribaldi F, Lathuiliere A, Ashton NJ, et al
    Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
    J Neurol. 2024;271:2053-2066.
    >> Share

  7. O'CONNOR A, Lyons S, Finnegan M, Walsh J, et al
    Expanding the phenotype of psychiatric-onset prodromal dementia with Lewy bodies.
    J Neurol. 2024;271:2125-2128.
    >> Share

  8. SARTO J, Esteller-Gauxax D, Tort-Merino A, Guillen N, et al
    Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort.
    J Neurol. 2024;271:1973-1984.
    >> Share

    March 2024
  9. LANGERSCHEIDT F, Wied T, Al Kabbani MA, van Eimeren T, et al
    Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
    J Neurol. 2024 Mar 30. doi: 10.1007/s00415-024-12314.
    >> Share

  10. SINGH NA, Graff-Radford J, Machulda MM, Carlos AF, et al
    Atypical Alzheimer's disease: new insights into an overlapping spectrum between the language and visual variants.
    J Neurol. 2024 Mar 29. doi: 10.1007/s00415-024-12297.
    >> Share

  11. PENG M, Yuan S, Lu D, Ling Y, et al
    Dietary inflammatory index, genetic susceptibility and risk of incident dementia: a prospective cohort study from UK biobank.
    J Neurol. 2024;271:1286-1296.
    >> Share

    February 2024
  12. SUBOTIC A, Gee M, Nelles K, Ba F, et al
    Gray matter loss relates to dual task gait in Lewy body disorders and aging.
    J Neurol. 2024;271:962-975.
    >> Share

    January 2024
  13. HUANG M, Landin-Romero R, Matis S, Dalton MA, et al
    Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia.
    J Neurol. 2024 Jan 24. doi: 10.1007/s00415-023-12172.
    >> Share

  14. GENG C, Meng K, Tang Y
    Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer's disease: a Mendelian randomization analysis and mediation analysis.
    J Neurol. 2024 Jan 22. doi: 10.1007/s00415-023-12176.
    >> Share

  15. HENNEY AE, Gillespie CS, Alam U, Hydes TJ, et al
    High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies.
    J Neurol. 2024;271:198-210.
    >> Share

    December 2023
  16. MASSA F, Martinuzzo C, Gomez de San Jose N, Pelagotti V, et al
    Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    J Neurol. 2023 Dec 29. doi: 10.1007/s00415-023-12154.
    >> Share

  17. RONAT L, Hanganu A, Chylinski D, Van Egroo M, et al
    Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.
    J Neurol. 2023 Dec 19. doi: 10.1007/s00415-023-12131.
    >> Share

    November 2023
  18. ST-GEORGES MA, Wang L, Chapleau M, Migliaccio R, et al
    Social cognition and behavioral changes in patients with posterior cortical atrophy.
    J Neurol. 2023 Nov 30. doi: 10.1007/s00415-023-12089.
    >> Share

  19. PEREZ-MILLAN A, Borrego-Ecija S, Falgas N, Junca-Parella J, et al
    Cortical thickness modeling and variability in Alzheimer's disease and frontotemporal dementia.
    J Neurol. 2023 Nov 27. doi: 10.1007/s00415-023-12087.
    >> Share

  20. VRILLON A, Ashton NJ, Karikari TK, Gotze K, et al
    Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
    J Neurol. 2023 Nov 11. doi: 10.1007/s00415-023-12066.
    >> Share

    September 2023
  21. STAM D, Rosseel S, De Winter FL, Van den Bossche MJA, et al
    Facial expression recognition deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic investigation of effects of phenotypic variant, task modality, geographical region and symptomatic specificity.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11927.
    >> Share

  22. CHAN E, Bonifacio GB, Harrison C, Banerjee G, et al
    Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11977.
    >> Share

  23. DAMSGAARD L, Janbek J, Laursen TM, Waldemar G, et al
    Healthcare utilization prior to a diagnosis of young-onset Alzheimer's disease: a nationwide nested case-control study.
    J Neurol. 2023 Sep 5. doi: 10.1007/s00415-023-11974.
    >> Share

    July 2023
  24. PENA-BAUTISTA C, Alvarez-Sanchez L, Ferrer-Cairols I, Garcia-Valles L, et al
    Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
    J Neurol. 2023 Jul 28. doi: 10.1007/s00415-023-11899.
    >> Share

  25. MIZUTANI Y, Ohdake R, Tatebe H, Higashi A, et al
    Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.
    J Neurol. 2023 Jul 22. doi: 10.1007/s00415-023-11875.
    >> Share

  26. SAW AM, Hrastelj J, Robertson NP
    Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia.
    J Neurol. 2023 Jul 3. doi: 10.1007/s00415-023-11840.
    >> Share

    June 2023
  27. KUCIKOVA L, Zeng J, Munoz-Neira C, Muniz-Terrera G, et al
    Genetic risk factors of Alzheimer's Disease disrupt resting-state functional connectivity in cognitively intact young individuals.
    J Neurol. 2023 Jun 26. doi: 10.1007/s00415-023-11809.
    >> Share

    April 2023
  28. LING Y, Yuan S, Huang X, Tan S, et al
    The association of night shift work with the risk of all-cause dementia and Alzheimer's disease: a longitudinal study of 245,570 UK Biobank participants.
    J Neurol. 2023 Apr 6. doi: 10.1007/s00415-023-11672.
    >> Share

  29. FERRUCCI R, Cuffaro L, Capozza A, Rosci C, et al
    Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19.
    J Neurol. 2023;270:1823-1834.
    >> Share

  30. TAYLOR NL, Shine JM
    A whole new world: embracing the systems-level to understand the indirect impact of pathology in neurodegenerative disorders.
    J Neurol. 2023;270:1969-1975.
    >> Share

  31. CONSTANTINIDES VC, Tentolouris-Piperas V, Paraskevas GP, Pyrgelis ES, et al
    Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies.
    J Neurol. 2023;270:2059-2068.
    >> Share

    March 2023
  32. SEMENKOVA A, Piguet O, Johnen A, Schroeter ML, et al
    The Behavioural Dysfunction Questionnaire discriminates behavioural variant frontotemporal dementia from Alzheimer's disease dementia and major depressive disorder.
    J Neurol. 2023 Mar 23. doi: 10.1007/s00415-023-11666.
    >> Share

  33. FILIPPI M, Cecchetti G, Cagnin A, Marra C, et al
    Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline.
    J Neurol. 2023 Mar 9. doi: 10.1007/s00415-023-11642.
    >> Share

    February 2023
  34. JISKOOT LC, Russell LL, Greaves CV, van Schaik E, et al
    Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders.
    J Neurol. 2023 Feb 22. doi: 10.1007/s00415-023-11596.
    >> Share

  35. CHU H, Huang C, Miao Y, Ren C, et al
    The association of subjective sleep characteristics and plasma biomarkers of Alzheimer's disease pathology in older cognitively unimpaired adults with higher amyloid-beta burden.
    J Neurol. 2023 Feb 20. doi: 10.1007/s00415-023-11626.
    >> Share

  36. EDWARDS M, Corkill R
    Disease-modifying treatments in Alzheimer's disease.
    J Neurol. 2023 Feb 16. doi: 10.1007/s00415-023-11602.
    >> Share

    January 2023
  37. CRETIN B, Philippi N, Bousiges O, Blanc F, et al
    Transient epileptic amnesia: a retrospective cohort study of 127 cases, including CSF amyloid and tau features.
    J Neurol. 2023 Jan 30. doi: 10.1007/s00415-023-11576.
    >> Share

  38. FU X, Chu C, Pang Y, Cai H, et al
    A blood mRNA panel that differentiates Alzheimer's disease from other dementia types.
    J Neurol. 2023 Jan 7. doi: 10.1007/s00415-023-11558.
    >> Share

    December 2022
  39. LIAMPAS I, Siokas V, Lyketsos CG, Dardiotis E, et al
    Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women.
    J Neurol. 2022 Dec 26. doi: 10.1007/s00415-022-11541.
    >> Share

  40. FAN Z, Li Z, Zhao S, Chen Y, et al
    Salivary Abeta(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis.
    J Neurol. 2022 Dec 23. doi: 10.1007/s00415-022-11509.
    >> Share

  41. LEOCADI M, Canu E, Paldino A, Agosta F, et al
    Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI review.
    J Neurol. 2022 Dec 13. doi: 10.1007/s00415-022-11518.
    >> Share

    November 2022
  42. LI Y, Chen Z, Wang Q, Lv X, et al
    Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer's disease by integrated bioinformatics.
    J Neurol. 2022 Nov 18. pii: 10.1007/s00415-022-11476.
    >> Share

  43. LOPEZ-ORTIZ S, Lista S, Valenzuela PL, Pinto-Fraga J, et al
    Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses.
    J Neurol. 2022 Nov 7. pii: 10.1007/s00415-022-11454.
    >> Share

    October 2022
  44. FERNANDES M, Mari L, Chiaravalloti A, Paoli B, et al
    (18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.
    J Neurol. 2022;269:5356-5367.
    >> Share

    September 2022
  45. ACHENBACH J, Faissner S, Saft C
    Resurrection of sildenafil: potential for Huntington's Disease, too?
    J Neurol. 2022;269:5144-5150.
    >> Share

  46. RHODUS EK, Barber J, Kryscio RJ, Abner EL, et al
    Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia.
    J Neurol. 2022;269:5105-5113.
    >> Share

  47. ALTUNA M, Larumbe R, Zelaya MV, Moreno S, et al
    Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.
    J Neurol. 2022;269:4853-4862.
    >> Share

    August 2022
  48. SINGH NA, Graff-Radford J, Machulda MM, Schwarz CG, et al
    Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.
    J Neurol. 2022 Aug 24. pii: 10.1007/s00415-022-11330.
    >> Share

  49. DOUNAVI ME, Newton C, Jenkins N, Mak E, et al
    Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
    J Neurol. 2022;269:4299-4309.
    >> Share

    July 2022
  50. MENARDI A, Dotti L, Ambrosini E, Vallesi A, et al
    Transcranial magnetic stimulation treatment in Alzheimer's disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization.
    J Neurol. 2022 Jul 4. pii: 10.1007/s00415-022-11236.
    >> Share

  51. LAFORCE RJ, Dallaire-Theroux C, Racine AM, Dent G, et al
    Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1.
    J Neurol. 2022;269:3579-3587.
    >> Share

  52. ROSENBLUM Y, Shiner T, Bregman N, Fahoum F, et al
    Event-related oscillations differentiate between cognitive, motor and visual impairments.
    J Neurol. 2022;269:3529-3540.
    >> Share

    June 2022
  53. CLARK E, Faruque S, Mutebi C, Nagirimadugu NV, et al
    Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias: a systematic review.
    J Neurol. 2022 Jun 1. pii: 10.1007/s00415-022-11186.
    >> Share

    March 2022
  54. ISELLA V, Crivellaro C, Formenti A, Musarra M, et al
    Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.
    J Neurol. 2022 Mar 26. pii: 10.1007/s00415-022-11086.
    >> Share

  55. GIACOMUCCI G, Mazzeo S, Bagnoli S, Ingannato A, et al
    Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
    J Neurol. 2022 Mar 14. pii: 10.1007/s00415-022-11055.
    >> Share

  56. BANERJEE G, Forsgard N, Ambler G, Keshavan A, et al
    Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
    J Neurol. 2022;269:1470-1475.
    >> Share

    February 2022
  57. CORRIVEAU-LECAVALIER N, Machulda MM, Botha H, Graff-Radford J, et al
    Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases.
    J Neurol. 2022 Feb 25. pii: 10.1007/s00415-022-11025.
    >> Share

    January 2022
  58. LARDEUX P, Fourier A, Peter E, Dorey A, et al
    Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis.
    J Neurol. 2022;269:377-388.
    >> Share

    December 2021
  59. SCHUMACHER J, Taylor JP, Hamilton CA, Firbank M, et al
    Functional connectivity in mild cognitive impairment with Lewy bodies.
    J Neurol. 2021;268:4707-4720.
    >> Share

  60. SANTORO JD, Pagarkar D, Chu DT, Rosso M, et al
    Neurologic complications of Down syndrome: a systematic review.
    J Neurol. 2021;268:4495-4509.
    >> Share

    November 2021
  61. ROSSO M, Chu D
    Gaetano Perusini (1879-1915).
    J Neurol. 2021;268:4400-4401.
    >> Share

    October 2021
  62. CONTADOR J, Perez-Millan A, Guillen N, Tort-Merino A, et al
    Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer's disease.
    J Neurol. 2021 Oct 19. pii: 10.1007/s00415-021-10851.
    >> Share

  63. PLEEN J, Townley R
    Alzheimer's disease clinical trial update 2019-2021.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10790.
    >> Share

  64. ARMON C, Wolfson S, Margalit R, Avraham L, et al
    Estimating the X chromosome-mediated risk for developing Alzheimer's disease.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10826.
    >> Share

  65. OLIVIERI P, Lebouvier T, Hardouin JB, Courtemanche H, et al
    LeSCoD: a new clinical scale for the detection of Lewy body disease in neurocognitive disorders.
    J Neurol. 2021;268:3886-3896.
    >> Share

    July 2021
  66. ULUGUT H, Stek S, Wagemans LEE, Jutten RJ, et al
    The natural history of primary progressive aphasia: beyond aphasia.
    J Neurol. 2021 Jul 3. pii: 10.1007/s00415-021-10689.
    >> Share

    June 2021
  67. MOHAMED AZ, Nestor PJ, Cumming P, Nasrallah FA, et al
    Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.
    J Neurol. 2021 Jun 30. pii: 10.1007/s00415-021-10669.
    >> Share

    May 2021
  68. LIU X, Dounavi ME, Ritchie K, Wells K, et al
    Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals.
    J Neurol. 2021;268:1962-1971.
    >> Share

    April 2021
  69. WEI Y, Liu M, Wang D
    The propagation mechanisms of extracellular tau in Alzheimer's disease.
    J Neurol. 2021 Apr 28. pii: 10.1007/s00415-021-10573.
    >> Share

  70. FIRBANK MJ, O'Brien JT, Durcan R, Allan LM, et al
    Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling.
    J Neurol. 2021;268:1284-1294.
    >> Share

    January 2021
  71. ORAD RI, Shiner T
    Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.
    J Neurol. 2021 Jan 29. pii: 10.1007/s00415-021-10402.
    >> Share

  72. SEGHEZZO G, Van Hoecke Y, James L, Davoren D, et al
    Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing.
    J Neurol. 2021 Jan 26. pii: 10.1007/s00415-021-10403.
    >> Share

    May 2020
  73. DONAGHY PC, Firbank M, Mitra D, Petrides G, et al
    Microbleeds in dementia with Lewy bodies.
    J Neurol. 2020;267:1491-1498.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016